We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleConcomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.AuthorsXu, C F; Xue, Z; Bing, N; King, K S; McCann, L A; de Souza, P L; Goodman, V L; Spraggs, C F; Mooser, V E; Pandite, L NPublicationAnnals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 9, p2470ISSN1569-8041Publication typeResearchDOI10.1093/annonc/mds249